Vimarsana
Biggest News Aggregation in the World

Cell Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Programs Today - Breaking & Trending Today

Ginkgo Bioworks Holdings Inc (DNA) Reports Decline in 2023 Revenue Amid Transition and ... - Vimarsana News

Ginkgo Bioworks Holdings Inc (DNA) Reports Decline in 2023 Revenue Amid Transition and ...

Company Sees Growth in Cell Engineering Services and Advances in Biosecurity Segment

Source: yahoo.com
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results - Vimarsana News

Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023 Financial Results

$251 million of Total revenue in 2023 $139 million in Cell Engineering services revenue, representing 31% growth over 2022 78 new Cell Programs added in 2023, representing 32% growth over 2022 and...

Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference - Vimarsana News

Ginkgo Bioworks Provides Business Updates at J.P. Morgan Healthcare Conference

Expects to meet 2023 new program and revenue guidance ranges Ended the year with nearly $950 million in cash and cash equivalents, a strong balance sheet providing multi-year runway as Ginkgo sees...

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments - Ginkgo Bioworks Holdings (NYSE:DNA) - Vimarsana News

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments - Ginkgo Bioworks Holdings (NYSE:DNA)

Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments - Vimarsana News

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments

Wednesday, Ginkgo Bioworks Holdings Inc DNA released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.…

Source: biztoc.com